INCATE

📢 Final Call: "Advances in Bacteriophage Research and Development with Therapeutic Applications" Attention phage researchers, clinicians, and industry leaders: this is your last chance to contribute to our collection on cutting-edge bacteriophage research and therapeutic applications! We’re seeking groundbreaking manuscripts on: - Phage-based treatments revolutionizing infection control - Phage-derived enzymes tackling antimicrobial resistance - Innovative approaches harnessing the power of bacteriophages Why bacteriophages? - Precision-target harmful bacteria - Safe, eco-friendly, and AMR-fighting alternatives - Utilize one of Earth’s most abundant biological tools 🗓️ Closing March 31, 2025! Be part of this transformative field: submit your work today! Info here➡️ https://lnkd.in/eRJ2DqQ5

CARB-X 2025 Funding Round: new details available! CARB-X has announced its 2025 funding round, focusing on two key themes: - Direct-acting small molecule therapeutics for Gram-negative bacteria - Diagnostics for typhoid fever in low-resource settings Join the public webinars next week, to learn about the funding scope, application process, and more: 📅 Thursday, April 3 | 7pm ET – https://lnkd.in/eHy5j5xF 📅 Friday, April 4 | 9am ET – https://lnkd.in/eFjCmiht Learn more about the funding themes, TPPs, and entry criteria: https://lnkd.in/dh5_kQ_r Expressions of Interest open April 16 (10am ET) – April 30 (11.59pm ET). A second cycle will follow later in 2025.

Two Weeks to Go: "Surviving Superbugs – A Dance To Resist" with Interfinity! Join us for an inspiring fusion of science and art to explore the urgent challenge of antibiotic resistance. Panel Discussion: Leading experts, including Prof. Dr. Christoph Dehio & Prof. Dr. Nina Khanna (NCCR AntiResist ), will discuss the health and sociopolitical impacts of antibiotic resistance. With insights from: - Anne Lévy (Director, FOPH) - Dr. Ken Bradley (Global Head Infectious Disease Discovery, Roche) - Dr. Marc Gitzinger (CEO & Co-Founder, BioVersys AG) - Dr. Mark Jones (Head Global Affairs, Basilea Pharmaceutica & Swiss RTA Board) - Martin Heidecker (@AMR Action Fund) Moderated by Prof. Dr. Marcel Tanner (Swiss Tropical and Public Health Institute) 📅 Monday, April 7, 2025 | 7.30pm CEST 📍 Biozentrum, University of Basel Register at office@interfinity.ch | Free admission "Surviving Superbugs – A Dance To Resist" – A breathtaking performance blending movement and microbiology. 🗓️ April 9 & 10, 2025 | 8.30pm CEST 📍 Voltahalle Basel More info: https://lnkd.in/ek5cWHnh Are you as curious as we are? Let’s explore this vital issue together!

Curious about how Artificial Intelligence is revolutionizing antibiotic design? Join the next Global Antibiotic R&D Partnership (GARDP) REVIVE webinar, "Charting New Frontiers in AI for Antibiotic Design," to discover the latest advancements in AI and machine learning for developing new antibiotics. Speakers: - Jon Stokes, Assistant Professor, McMaster University - Kurt Thorn, Chief Technology Officer, ArrePath, Inc. Moderator: - Akhila Kosaraju, Chief Executive Officer, Phare Bio 📅 April 3, 2025 🕔 5pm – 6.30pm CEST Register now ➡️ https://lnkd.in/eVPF2XVx Don't miss this chance to explore the cutting edge of AI-driven antibiotic innovation! 

Today is World Tuberculosis Day. Tuberculosis (TB) is both preventable and curable — yet every day, nearly 3,425 lives are lost to TB, and 30,000 people contract this disease. According to the World Health Organization, in 2023, the global fight against TB made a significant impact: - 79 million lives have been saved since 2000 through global efforts - 10.8 million people fell ill with TB last year - 1.25 million lives were lost to TB in 2023 We must continue working together to prevent, treat and eliminate. 

World Water Day: protecting Water, combating AMR Today, on World Water Day, we highlight the vital connection between clean water and antimicrobial resistance (AMR). - Antibiotic residues in wastewater can fuel resistance, allowing bacteria to adapt and survive - Hospital and agricultural runoff can spread resistant pathogens into natural water sources - Global water systems act as highways for AMR, making it a challenge that knows no borders To fight AMR, we must prioritize clean water, proper wastewater management, and responsible antibiotic use. A One Health approach, uniting human, animal, and environmental health, is key to safeguarding our future. At INCATE, we support innovators tackling AMR, because protecting water means protecting global health.

📢 Applications for the Interdisciplinary Course on Antibiotics and Resistance (ICARe) are now open! Antibiotic discovery and resistance are evolving rapidly, yet there’s a growing gap in hands-on experience and deep expertise in the field. ICARe aims to close this gap by bringing together top leaders from academia and industry with early-career scientists. Over 9 intensive days, participants will explore cutting-edge approaches to antibiotic discovery, resistance mechanisms, and their impact, through a combination of formal instruction and hands-on bioinformatics training. 🗓️ Application deadline: June 21, 2025 Info & application ➡️ https://lnkd.in/gUWX3-u

📢 Call on "Advances in Bacteriophage Research and Development with Therapeutic Applications" closing soon! Attention all #phage researchers, clinicians, and industry professionals! INCATE invites you to contribute to an exciting collection: Advances in Bacteriophage Research and Development with Therapeutic Applications. We are seeking groundbreaking manuscripts showcasing the transformative power of #phagetherapy. Whether you're pioneering bacteriophage-based treatments or harnessing phage-derived enzymes to combat infections, this is your opportunity to highlight your innovative work! Why bacteriophages? These natural bacterial predators are reshaping infection control by: - Targeting harmful bacteria with precision. - Offering safe, eco-friendly, and effective alternatives to fight antimicrobial resistance. - Harnessing the power of one of the most abundant organisms on Earth! Don’t miss your chance to contribute to this cutting-edge field. Learn more and submit here ➡️https://lnkd.in/eRJ2DqQ5

The rise of antimicrobial resistance (AMR) is often attributed to the overuse of antibiotics. However, researchers at the Indian Institute of Science (IISc) and Kiel University have uncovered another surprising factor: microbial interactions in soil. Their study reveals that a species of predatory bacteria can drive AMR development, even in the absence of antibiotic exposure. What does this mean for our understanding of AMR in natural environments beyond human influence? Read more here ➡️ https://lnkd.in/eFHc6tdC

The BEAM Alliance has released its 3rd BEAM Barometer on AMR, highlighting the ongoing challenges in financing innovation. While the 2024 results show some improvement over 2023, there's still a long road ahead. The key takeaway? SMEs continue to fight for survival, but they persist! Read the whole document here ➡️ https://lnkd.in/enQmrvgM